BET inhibition reveals glycolytic vulnerability via HIF1α in triple-negative breast cancer
In a groundbreaking study poised to reshape the therapeutic landscape of aggressive breast cancers, researchers have uncovered a novel metabolic ...
In a groundbreaking study poised to reshape the therapeutic landscape of aggressive breast cancers, researchers have uncovered a novel metabolic ...
Mitochondria, long celebrated as the cellular powerhouses, have emerged as pivotal arbiters of cancer progression, especially in aggressive breast cancers ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine